Search

everythinglearnresearchcommunity

for

Search:↓

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Lower LDL-c levels predict higher COVID-19 mortality.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Hair loss link to severe COVID-19 unclear.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Low testosterone levels may lead to more severe COVID-19 outcomes.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Testosterone's effects on COVID-19 are unclear and need more research.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Some drugs may help treat both COVID-19 and radiation injury.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.